These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29190318)

  • 21. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Smad signaling in kidney disease.
    Zhang Y; Wang S; Liu S; Li C; Wang J
    Int Urol Nephrol; 2015 Dec; 47(12):1965-75. PubMed ID: 26433882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
    Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
    Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta family signal transduction in Drosophila development: from Mad to Smads.
    Raftery LA; Sutherland DJ
    Dev Biol; 1999 Jun; 210(2):251-68. PubMed ID: 10357889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-Wide RNAi Screening to Dissect the TGF-β Signal Transduction Pathway.
    Chen X; Xu L
    Methods Mol Biol; 2016; 1344():365-77. PubMed ID: 26520138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Smad TGF-beta signals.
    Moustakas A; Heldin CH
    J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
    Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
    Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β Signaling from Receptors to Smads.
    Hata A; Chen YG
    Cold Spring Harb Perspect Biol; 2016 Sep; 8(9):. PubMed ID: 27449815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of TGF-beta receptor/Smad signal transduction.
    Itoh S; ten Dijke P
    Curr Opin Cell Biol; 2007 Apr; 19(2):176-84. PubMed ID: 17317136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β family co-receptor function and signaling.
    Nickel J; Ten Dijke P; Mueller TD
    Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):12-36. PubMed ID: 29293886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New regulatory mechanisms of TGF-beta receptor function.
    Kang JS; Liu C; Derynck R
    Trends Cell Biol; 2009 Aug; 19(8):385-94. PubMed ID: 19648010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.
    Nyati S; Schinske-Sebolt K; Pitchiaya S; Chekhovskiy K; Chator A; Chaudhry N; Dosch J; Van Dort ME; Varambally S; Kumar-Sinha C; Nyati MK; Ray D; Walter NG; Yu H; Ross BD; Rehemtulla A
    Sci Signal; 2015 Jan; 8(358):ra1. PubMed ID: 25564677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.
    Tiwari R; Bargmann W; Bose HR
    Virology; 2011 Apr; 413(1):60-71. PubMed ID: 21345476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.